Clinical Experience of Combined Treatment of Pituitary Prolactinoma Complicated with Type 2 Diabetes Based on Individual-Disease/Syndrome-Target Pathway
QIAO Yun
AN Xuedong
BU Shuai
HUANG Yajie
ZHANG Lingrui
Abstract：Modern comorbidity research advocates a shift from a disease-oriented approach to an individual-oriented approach.The author based on clinical practice,advocates that diagnostic and therapeutic perspectives should focus from the macro to the micro,with an individual-oriented approach and a pathway based on the individual-disease/syndrome-target,that is,identifying the patient's constitution firstly,and fully understanding individual differences;grasping the characteristics of the disease,combining with the current syndromes,to fully combine disease identification and syndrome differentiation;skillfully combining modern pharma-cology of Chinese medicinals,using targeting drugs with precise pharmacological effects to comprehen-sively achieve a precise,personalized comorbidity diagnosis and treatment model.This approach has been used in clinic for many years with significant universality.This article attached a case of treating pituitary prolactinoma complicated with type 2 diabetes using the individual-disease/syndrome-target pathway.
Keywords：prolactin-secreting pituitary adenomatype 2 diabetesconstitutioncombination of disease and syndrometargeted drugstraditional Chinese medicine
Publication Date：2025-06-05
Online Publishing Date：2026-05-22(First online date of this platform, not the publication date of the document)
Pages：5( 695-699 )